Table 1.

Group demographics, neuropathological stages and genotype of study cohort

N.a. = not available. N.s. = no significant difference between groups. A = controls vs. pure AD; B = controls vs. pure DLB; C = controls vs. mixed DLB + AD; D = pure AD vs. pure DLB; E = pure AD vs. mixed DLB + AD; F = pure DLB vs. mixed DLB + AD. CAA = cerebral amyloid angiopathy; CERAD = Consortium to Establish a Registry for Alzheimer Disease; APOEε = apolipoprotein E; HLA-DRB1*04 = human leukocyte antigen DRB1*04 subtypes; GBA1 = glucocerebrosidase gene 1. Groups were compared using a one-way ANOVA with post-hoc t-tests for continuous and a Fisher’s exact test with post-hoc pairwise comparisons for categorical variables. Post-hoc tests were performed if overall test was significant